Argentina passes urgent ephedrine regulations
This article was originally published in Scrip
A new resolution will further restrict the production, marketing and use of ephedrine- and pseudoephedrine-based products in Argentina as abuse of these products continues to rise. The resolution came into effect on December 19th, a day after it was published in the official journal.
You may also be interested in...
While information sharing is key to cross-country collaborations on access to medicines and can lead to major benefits, it is hard to sell to political leaders and the media, says a report from the World Health Organization’s regional office for Europe.
The European Commission says it will publish its review of the EU orphan drug legislation in the coming days.
The UK has formally withdrawn its ratification of the Unified Patent Court Agreement, adding to the uncertainty over its future.